GALECTIN THERAPEUTICS INC Quarterly Return On Assets in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Galectin Therapeutics Inc quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2024.
  • Galectin Therapeutics Inc Return On Assets for the quarter ending September 30, 2024 was -163 %, a 18.2% increase year-over-year.
  • Galectin Therapeutics Inc annual Return On Assets for 2023 was -181 %, a 15.3% decline from 2022.
  • Galectin Therapeutics Inc annual Return On Assets for 2022 was -157 %, a 75.2% decline from 2021.
  • Galectin Therapeutics Inc annual Return On Assets for 2021 was -89.7 %, a 42.4% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -163 +36.3 +18.2% Jul 1, 2024 Sep 30, 2024
Q2 2024 -170 +30.1 +15% Apr 1, 2024 Jun 30, 2024
Q1 2024 -170 +18.9 +10% Jan 1, 2024 Mar 31, 2024
Q4 2023 -181 -24 -15.3% Oct 1, 2023 Dec 31, 2023
Q3 2023 -199 -80.6 -67.9% Jul 1, 2023 Sep 30, 2023
Q2 2023 -201 -99.3 -98.1% Apr 1, 2023 Jun 30, 2023
Q1 2023 -189 -96.4 -104% Jan 1, 2023 Mar 31, 2023
Q4 2022 -157 -67.5 -75.2% Oct 1, 2022 Dec 31, 2022
Q3 2022 -119 -18.1 -18% Jul 1, 2022 Sep 30, 2022
Q2 2022 -101 -5.96 -6.25% Apr 1, 2022 Jun 30, 2022
Q1 2022 -92.9 -10.8 -13.2% Jan 1, 2022 Mar 31, 2022
Q4 2021 -89.7 -26.7 -42.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 -101 -51.1 -103% Jul 1, 2021 Sep 30, 2021
Q2 2021 -95.3 -57.2 -150% Apr 1, 2021 Jun 30, 2021
Q1 2021 -82.1 -52.6 -178% Jan 1, 2021 Mar 31, 2021
Q4 2020 -63 -29.7 -89.5% Oct 1, 2020 Dec 31, 2020
Q3 2020 -49.4 -12.3 -33% Jul 1, 2020 Sep 30, 2020
Q2 2020 -38.1 +17.5 +31.4% Apr 1, 2020 Jun 30, 2020
Q1 2020 -29.5 +94.8 +76.3% Jan 1, 2020 Mar 31, 2020
Q4 2019 -33.2 +122 +78.6% Oct 1, 2019 Dec 31, 2019
Q3 2019 -37.2 +134 +78.3% Jul 1, 2019 Sep 30, 2019
Q2 2019 -55.6 +162 +74.5% Apr 1, 2019 Jun 30, 2019
Q1 2019 -124 +120 +49.2% Jan 1, 2019 Mar 31, 2019
Q4 2018 -155 +32.8 +17.4% Oct 1, 2018 Dec 31, 2018
Q3 2018 -171 -11.3 -7.04% Jul 1, 2018 Sep 30, 2018
Q2 2018 -218 -83.6 -62.2% Apr 1, 2018 Jun 30, 2018
Q1 2018 -245 -123 -100% Jan 1, 2018 Mar 31, 2018
Q4 2017 -188 -70.7 -60.1% Oct 1, 2017 Dec 31, 2017
Q3 2017 -160 -56.9 -55.3% Jul 1, 2017 Sep 30, 2017
Q2 2017 -134 -31.6 -30.7% Apr 1, 2017 Jun 30, 2017
Q1 2017 -122 -31.7 -35% Jan 1, 2017 Mar 31, 2017
Q4 2016 -118 -40.9 -53.4% Oct 1, 2016 Dec 31, 2016
Q3 2016 -103 -32.2 -45.5% Jul 1, 2016 Sep 30, 2016
Q2 2016 -103 -46 -81% Apr 1, 2016 Jun 30, 2016
Q1 2016 -90.4 -41 -83% Jan 1, 2016 Mar 31, 2016
Q4 2015 -76.6 -28.9 -60.7% Oct 1, 2015 Dec 31, 2015
Q3 2015 -70.8 -18.5 -35.2% Jul 1, 2015 Sep 30, 2015
Q2 2015 -56.8 +7.87 +12.2% Apr 1, 2015 Jun 30, 2015
Q1 2015 -49.4 +40 +44.8% Jan 1, 2015 Mar 31, 2015
Q4 2014 -47.7 +99.3 +67.6% Oct 1, 2014 Dec 31, 2014
Q3 2014 -52.3 +94.6 +64.4% Jul 1, 2014 Sep 30, 2014
Q2 2014 -64.7 +65.7 +50.4% Apr 1, 2014 Jun 30, 2014
Q1 2014 -89.4 +16.5 +15.6% Jan 1, 2014 Mar 31, 2014
Q4 2013 -147 -68.9 -88.4% Oct 1, 2013 Dec 31, 2013
Q3 2013 -147 -55.5 -60.7% Jul 1, 2013 Sep 30, 2013
Q2 2013 -130 -38.5 -41.9% Apr 1, 2013 Jun 30, 2013
Q1 2013 -106 +3.14 +2.88% Jan 1, 2013 Mar 31, 2013
Q4 2012 -78 Oct 1, 2012 Dec 31, 2012
Q3 2012 -91.4 Jul 1, 2012 Sep 30, 2012
Q2 2012 -91.9 Mar 29, 2012 Jun 30, 2012
Q1 2012 -109 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.